Target Audience

Physicians, dementia specialists, neuroscientists, university medical/science faculty, advanced trainees (i.e., graduate students, fellows, medical residents), scientists and professionals from industry, neuropsychologists, and other professional or lay individuals with interests in novel therapies for protein misfolding disorders.